CD4 and intrahepatic cholangiocarcinoma: When looking at patients with ICC after hypofractionated proton therapy, strangely a longer OS was significantly correlated with a higher number of naïve (CD4+CD25+) and memory (CD4+CD127+) T cells in the blood at the beginning of hypofractionated proton therapy (189).